Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F7NWR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,830
Award facts
- Contract value 100% obligated
- $18,830.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,830 to AmerisourceBergen Drug Corp on January 23, 2026, for the supply of Ondansetron ODT 4 mg tablets (30-count packages). This non-set-aside, competitively awarded contract features firm fixed pricing and an ultimate completion date of January 26, 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal government agencies with a comprehensive portfolio of prescription medications, over-the-counter drugs, medical devices, and specialized healthcare commodities.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion IDC valued through December 2026 that enables global pharmaceutical support for military healthcare programs. The IDC serves as a flexible procurement vehicle allowing AmerisourceBergen to supply a vast range of medications and medical supplies to support Defense Health Agency operations, the U.S. Coast Guard, and other government healthcare systems. The ondansetron tablets being procured represent a standard pharmaceutical commodity commonly used for nausea and vomiting management in military and veteran healthcare settings.
Quick answers
Who was awarded contract SPE2DR26F7NWR?
SPE2DR26F7NWR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F7NWR worth?
The government has obligated $18,830 on SPE2DR26F7NWR.
Is contract SPE2DR26F7NWR an order under another contract?
Yes. SPE2DR26F7NWR is a delivery order under SPE2DR25D7059, an indefinite delivery contract.
Was contract SPE2DR26F7NWR competed?
The extent of competition for SPE2DR26F7NWR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award